A detailed history of Gilder Gagnon Howe & CO LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 75,559 shares of CMPS stock, worth $645,273. This represents 0.01% of its overall portfolio holdings.

Number of Shares
75,559
Previous 76,556 1.3%
Holding current value
$645,273
Previous $653,000 1.23%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-997 Reduced 1.3%
75,559 $645,000
Q2 2024

Aug 14, 2024

BUY
N/A
761 Added 1.0%
76,556 $653,000
Q1 2024

May 15, 2024

BUY
N/A
45,536 Added 150.49%
75,795 $647,000
Q4 2023

Feb 14, 2024

BUY
N/A
30,259 New
30,259 $258,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.